Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance
Interview with Rachael Lawrance The FDA is developing a series of four methodological patient-focused drug development (PFDD) guidance documents to address, in a stepwise manner, how stakeholders can collect and submit patient experience data and other relevant information from patients and caregivers for medical product development and regulatory decision making. In today’s episode, we discuss …
Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance Read More »